yes. It did work.. I then split the fastq files per barcode using fastx barcode splitter. However, it still did not solve my problem of less number of reads being aligned after running tophat. Also, fastq files I obtained from fastx and casava were totally different!
-
-
How did you run casava? What is your input for fastx barcode splitter and how did you start it? And, what is "different"? What did you expect?Originally posted by biofreak View Post
SvenComment
-
well my barcodes are not illumina but are nugen. I ran casava normally with the added
use-bases-mask parameter. it did not complain and generated fastq files. When I ran tophat with these files, it somehow could not align most of the reads. Final read count of SAM files was in thousands or even less in some cases.
I then generated 1 fastq files per lane through casava ignoring the barcodes. Then used barcodespliiter to split the fastq file according to the barcode.
For any sample, fastq file generated this way did not match with the one generated by casava. (in terms of number of lines as well as contents).
Also, tophat alignment does better job then the previous version. But the line counts of the SAM file are still not in millions.. I am not sure of my results at this point.Comment
-
I ran barsplitter as follows:
cat combined.fastq | fastx_barcode_splitter.pl --bcfile ../barcode1.txt --bol --mismatches 1 --prefix "lane1" --suffix ".fastq"
It creates separate fastq files but barcodes are retained in the file. So I removed those (first 4) first using:
fastx_trimmer -i fastqfile -o trim_fastqfile -f 5 -l 50 -Q 33
then ran tophat on the fastq files.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...Today, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment